Evidence map›Paper›PMID 42528886›Full record

ArticleFrontiers in medicine2026

Fibrinogen and catheter advancement difficulty: unveiling the key predictors of early

Shusheng Jiao, Hongjie Yang, Jianling Yang, Jianxia Zhi

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shusheng JiaoDepartment of Neurology, Bethune International Peace Hospital, Shijiazhuang, Hebei, China.
Hongjie YangDepartment of Medical Oncology, Bethune International Peace Hospital, Shijiazhuang, Hebei, China.
Jianling YangDepartment of General Surgery, Bethune International Peace Hospital, Shijiazhuang, Hebei, China.
Jianxia ZhiDepartment of Neurology, Bethune International Peace Hospital, Shijiazhuang, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Peripherally inserted central catheter (PICC) is widely used for medium-to-long-term venous access, but early puncture site bleeding within 48 h remains a common complication, potentially leading to increased morbidity and healthcare costs. Identifying independent risk factors is crucial for developing targeted prevention strategies. Methods: In this single-center, retrospective study, a consecutive cohort of patients who successfully underwent PICC insertion between March 2024 and March 2025 was enrolled. The study population was divided based on the criterion of Results: A total of 375 patients were included in the final analysis, with an Conclusion: Lower fibrinogen level and catheter advancement difficulty are independent risk factors for early PICC-related bleeding, while a tumor diagnosis appears protective. These findings highlight the importance of pre-procedural coagulation assessment and meticulous catheter placement.

Indexed as

catheter advancementfibrinogenin-situ hemorrhageperipherally inserted central catheter (PICC)tumor

Identifiers

PMID42528886
PMCPMC13415919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.